Cargando…

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations

Due to the rapid transmission of the coronavirus disease 2019 (COVID-19) causing serious public health problems and economic burden, the development of effective vaccines is a high priority for controlling the virus spread. Our group has previously demonstrated that the plant-produced receptor-bindi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siriwattananon, Konlavat, Manopwisedjaroen, Suwimon, Shanmugaraj, Balamurugan, Prompetchara, Eakachai, Ketloy, Chutitorn, Buranapraditkun, Supranee, Tharakhet, Kittipan, Kaewpang, Papatsara, Ruxrungtham, Kiat, Thitithanyanont, Arunee, Phoolcharoen, Waranyoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310282/ https://www.ncbi.nlm.nih.gov/pubmed/34358160 http://dx.doi.org/10.3390/vaccines9070744

Ejemplares similares

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters
por: Peletta, Allegra, et al.
Publicado: (2022)

DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice
por: Peletta, Allegra, et al.
Publicado: (2021)

Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice
por: Panapitakkul, Chalisa, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
por: Prompetchara, Eakachai, et al.
Publicado: (2023)

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
por: Prompetchara, Eakachai, et al.
Publicado: (2021)

Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies
por: Hanittinan, Oranicha, et al.
Publicado: (2022)

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines
por: Prompetchara, Eakachai, et al.
Publicado: (2014)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2023)

Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
por: Laotee, Sedthawut, et al.
Publicado: (2023)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins
por: Jirarojwattana, Perawat, et al.
Publicado: (2023)

Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
por: Phakham, Tanapati, et al.
Publicado: (2021)

Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Virus MIP-composites for SARS-CoV-2 detection in the aquatic environment
por: Sukjee, Wannisa, et al.
Publicado: (2022)

Alemtuzumab-induced elimination of HIV-1-infected immune cells
por: Ruxrungtham, Kiat, et al.
Publicado: (2016)

Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

Rapid and Efficient Cell-to-Cell Transmission of Avian Influenza H5N1 Virus in MDCK Cells Is Achieved by Trogocytosis
por: Kongsomros, Supasek, et al.
Publicado: (2021)

Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana
por: Hanittinan, Oranicha, et al.
Publicado: (2020)

Trogocytosis with monocytes associated with increased α2,3 sialic acid expression on B cells during H5N1 influenza virus infection
por: Kongsomros, Supasek, et al.
Publicado: (2020)

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
por: Jitobaom, Kunlakanya, et al.
Publicado: (2022)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
por: Keelapang, Poonsook, et al.
Publicado: (2023)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana
por: Boonyayothin, Wanuttha, et al.
Publicado: (2021)

Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity
por: Bulaon, Christine Joy I., et al.
Publicado: (2020)

Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
por: Kongsomros, Supasek, et al.
Publicado: (2021)

Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques
por: Keelapang, Poonsook, et al.
Publicado: (2023)

Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells
por: Aiewsakun, Pakorn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iutdo10j75g9l8curjglg6e5jr